NCT03874117 - Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

September 1, 2024

Study Completion Date

May 31, 2025

Conditions

HemodialysisKidney Failure, Chronic

Interventions

OTHER

Twice Weekly Hemodialysis then Thrice Weekly Hemodialysis

Twice weekly hemodialysis for 4 weeks, then thrice weekly hemodialysis for 4 weeks.

OTHER

Thrice Weekly Hemodialysis then Twice Weekly Hemodialysis

Thrice weekly hemodialysis for 4 weeks, then twice weekly hemodialysis for 4 weeks.

Trial Locations (3)

VA Palo Alto Health Care System, Palo Alto

Santa Clara Valley Medical Center, San Jose

Satellite HealthCare, San Jose

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Palo Alto Veterans Institute for Research

OTHER